Kidney transplant is an important treatment option that can improve quality of life and reduce dependence on dialysis in suitable patients with end-stage kidney failure. The process requires recipient evaluation, living donor suitability, surgical planning, infection risk, immunosuppressive treatment and long-term follow-up to be considered together.
The main complaint, duration of symptoms, previous treatments, accompanying diseases, medications, expectations and relevant examination findings are evaluated together.
The aim is not to apply the same treatment to every patient, but to understand the underlying mechanism and choose the safest suitable step.
Follow-up, medical treatment, minimally invasive procedures or surgery are discussed step by step according to the patient’s condition.
Kidney transplant may be considered in suitable patients with end-stage kidney failure when medical, surgical and immunological conditions are appropriate.
The goal is not only the operation itself, but a safe preparation and sustainable follow-up process.
In living donor transplant, donor safety is the first priority. Blood group, tissue compatibility, kidney function, anatomy and general health are evaluated.
The donor must be protected medically, surgically and ethically throughout the process.
Infection risk, urinary system problems, bladder function, previous surgeries and general suitability are reviewed before transplant.
Urological problems should be identified before the transplant whenever possible.
The transplanted kidney is placed and connected to vascular and urinary systems with careful surgical planning.
In the early period, kidney function, urine output, infection signs, wound healing and medication levels are followed.
Long-term success requires medication adherence, infection awareness, kidney function follow-up and coordinated care.
The patient should know warning symptoms and maintain regular controls.
Urinary system problems are reviewed before transplant planning.
Living donor evaluation prioritizes donor health and long-term safety.
Immunosuppressive therapy must be used regularly and monitored.
Early recognition of infection symptoms is important after transplant.
No. Suitability depends on kidney failure stage, general health, infection risk, immunological and surgical factors.
Yes. Donor safety is a central part of living donor transplant planning.
Yes. Medication adherence, infection prevention and kidney function monitoring are essential.
